TXNDC5 and Bloom syndrome: Taken together, these results demonstrate that inducing fibroblast-specific deletion of Txndc5 significantly lessens the development and progression of BLM-induced PF and preserves lung function, suggesting that targeting TXNDC5 in vivo could be a powerful and effective therapeutic approach to mitigate lung fibrosis.